San Antonio-based MR3 Health has developed a foot sensor to help patients monitor the health of their feet daily to prevent foot ulcers.
Two local doctoral students are capitalizing on recent victories in 11 pitch competitions to build bioscience startup NovoThelium.
A four-organization biotech team led by San Antonio-based nonprofit BioBridge Global (BBG) won a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC), a biomedical technology association that collaborates with multiple government agencies under an agreement with the U.S. Army Medical Research and Materiel Command (USAMRMC).
The Rivard Report concludes its four-part series on biotech in San Antonio with next steps for growing its bioscience industry. Part I about its origins is here, Part II about its growth is here, and Part III about its funding is here.
In the third part of the Rivard Report’s series on San Antonio’s biotech ecosystem – Part I about its origins is here, Part II about its growth here – we cover funding mechanisms for local biomedical companies.
Yesterday, the Rivard Report published an article on how biotech companies differentiate themselves from other tech startups and gave insight to our city’s biotech ecosystem’s origins.
Nanogel brain neural regeneration.
Scientists spend long years in postgraduate education and labs, so they can conduct research in their specialized area.
It’s Mayor Ivy Taylor’s turn to play host in San Antonio.
Cytocentrics, a German biotech and robotics company that is transforming laboratory testing of how pharmaceutical agents interact with human cells, is moving to San Antonio with plans to establish manufacturing operations here and create 300 high wage jobs over the next five years.